10-K Filing

CVS HEALTH CORP CIK: 64803 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0000064803-21-000011`
Period End Date	20201231
Filing Date	20210216
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	cvs-20201231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 102 Income Statement 87 Cash Flow Statement 139 Stockholders Equity 45 Comprehensive Income 27

Balance Sheet 102 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.68B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.06B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.85B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.37B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$3.00B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$19.62B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$21.74B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$17.52B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$18.50B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.28B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.11B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.73B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$50.30B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$56.37B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.73B	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$20.81B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.31B	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$17.31B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	423.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	425.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.61B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.04B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.73B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.86B	USD	Point-in-time
Goodwill	`Goodwill`	$79.55B	USD	Point-in-time
Goodwill	`Goodwill`	$79.75B	USD	Point-in-time
Goodwill	`Goodwill`	$78.68B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$33.12B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$31.14B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.46B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.88B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.62B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.60B	USD	Point-in-time
Total assets	`Assets`	$230.72B	USD	Point-in-time
Total assets	`Assets`	$222.45B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$11.14B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$10.49B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$15.79B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$13.60B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$7.94B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$6.88B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$2.99B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$4.27B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.13B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$14.24B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.56B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.83B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.60B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.64B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$3.78B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$5.44B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$53.30B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$62.02B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.76B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.93B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$59.21B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$64.70B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$6.79B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$7.29B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.46B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.88B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$7.44B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$7.01B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.16B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.35B	USD	Point-in-time
Total liabilities	`Liabilities`	$158.28B	USD	Point-in-time
Total liabilities	`Liabilities`	$161.01B	USD	Point-in-time
Commitments and contingencies (Note 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$45.97B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$46.51B	USD	Point-in-time
Treasury stock, at cost: 423 and 425 shares at December 31, 2020 and 2019	`TreasuryStockValue`	$28.23B	USD	Point-in-time
Treasury stock, at cost: 423 and 425 shares at December 31, 2020 and 2019	`TreasuryStockValue`	$28.18B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$49.64B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$45.11B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.41B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.02B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$69.39B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$63.86B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$312.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$306.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$230.72B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$222.45B	USD	Point-in-time

Income Statement 87 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$69.36B	USD	Annual
Premiums	`PremiumsEarnedNet`	$63.12B	USD	Annual
Premiums	`PremiumsEarnedNet`	$8.18B	USD	Annual
Net investment income	`NetInvestmentIncome`	$798.00M	USD	Annual
Net investment income	`NetInvestmentIncome`	$1.01B	USD	Annual
Net investment income	`NetInvestmentIncome`	$660.00M	USD	Annual
Total revenues	`Revenues`	$194.58B	USD	Annual
Total revenues	`Revenues`	$268.71B	USD	Annual
Total revenues	`Revenues`	$256.78B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$156.45B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$158.72B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$163.98B	USD	Annual
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$6.59B	USD	Annual
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$55.68B	USD	Annual
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$52.53B	USD	Annual
Goodwill impairments	`GoodwillImpairmentLoss`	-	USD	Annual
Goodwill impairments	`GoodwillImpairmentLoss`	-	USD	Annual
Goodwill impairments	`GoodwillImpairmentLoss`	$6.15B	USD	Annual
Operating expenses	`OperatingExpensesExcludingGoodwillImpairments`	$33.54B	USD	Annual
Operating expenses	`OperatingExpensesExcludingGoodwillImpairments`	$35.13B	USD	Annual
Operating expenses	`OperatingExpensesExcludingGoodwillImpairments`	$21.37B	USD	Annual
Total operating costs	`CostsAndExpenses`	$190.56B	USD	Annual
Total operating costs	`CostsAndExpenses`	$254.79B	USD	Annual
Total operating costs	`CostsAndExpenses`	$244.79B	USD	Annual
Operating income	`OperatingIncomeLoss`	$11.99B	USD	Annual
Operating income	`OperatingIncomeLoss`	$13.91B	USD	Annual
Operating income	`OperatingIncomeLoss`	$4.02B	USD	Annual
Interest expense	`InterestExpense`	$2.62B	USD	Annual
Interest expense	`InterestExpense`	$3.04B	USD	Annual
Interest expense	`InterestExpense`	$2.91B	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.44B	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-674.00M	USD	Point-in-time
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	Point-in-time
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-766.00M	USD	Point-in-time
Other income	`OtherNonoperatingIncomeExpense`	$4.00M	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$124.00M	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$206.00M	USD	Annual
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.41B	USD	Annual
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$9.00B	USD	Annual
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$9.77B	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$2.57B	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$2.00B	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$2.37B	USD	Annual
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$6.63B	USD	Annual
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$7.20B	USD	Annual
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-596.00M	USD	Annual
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-9.00M	USD	Annual
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	Annual
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	Annual
Net income (loss)	`ProfitLoss`	$7.19B	USD	Annual
Net income (loss)	`ProfitLoss`	$6.63B	USD	Annual
Net income (loss)	`ProfitLoss`	$-596.00M	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.00M	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$13.00M	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.00M	USD	Annual
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$7.18B	USD	Annual
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$-594.00M	USD	Annual
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$6.63B	USD	Annual
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$5.49	USD	Annual
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.57	USD	Annual
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$5.10	USD	Annual
Loss from discontinued operations attributable to CVS Health (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	$-0.01	USD	Annual
Loss from discontinued operations attributable to CVS Health (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	Annual
Loss from discontinued operations attributable to CVS Health (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	Annual
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$5.10	USD	Annual
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$5.48	USD	Annual
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$-0.57	USD	Annual
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.04B	shares	Annual
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.30B	shares	Annual
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	Annual
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.57	USD	Annual
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$5.47	USD	Annual
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$5.08	USD	Annual
Loss from discontinued operations attributable to CVS Health (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	Annual
Loss from discontinued operations attributable to CVS Health (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	$-0.01	USD	Annual
Loss from discontinued operations attributable to CVS Health (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	Annual
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$-0.57	USD	Annual
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$5.08	USD	Annual
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$5.46	USD	Annual
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.31B	shares	Annual
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.04B	shares	Annual
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.30B	shares	Annual
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$2.00	USD	Annual
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$2.00	USD	Annual
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$2.00	USD	Annual

Cash Flow Statement 139 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$248.39B	USD	Annual
Cash receipts from customers	`ProceedsFromCustomers`	$264.33B	USD	Annual
Cash receipts from customers	`ProceedsFromCustomers`	$186.52B	USD	Annual
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$148.98B	USD	Annual
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$149.66B	USD	Annual
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$158.64B	USD	Annual
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$55.12B	USD	Annual
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$6.90B	USD	Annual
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$52.24B	USD	Annual
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$29.76B	USD	Annual
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$28.93B	USD	Annual
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$17.23B	USD	Annual
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$894.00M	USD	Annual
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$644.00M	USD	Annual
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$955.00M	USD	Annual
Interest paid	`InterestPaidNet`	$2.80B	USD	Annual
Interest paid	`InterestPaidNet`	$2.95B	USD	Annual
Interest paid	`InterestPaidNet`	$2.90B	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$2.38B	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$2.93B	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$2.72B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$12.85B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.87B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$15.87B	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$817.00M	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$7.05B	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$6.47B	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$9.64B	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$7.53B	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$692.00M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.44B	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.04B	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.46B	USD	Annual
Proceeds from sale-leaseback transactions	`ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity`	$101.00M	USD	Annual
Proceeds from sale-leaseback transactions	`ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity`	$5.00M	USD	Annual
Proceeds from sale-leaseback transactions	`ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity`	-	USD	Annual
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$866.00M	USD	Annual
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$42.23B	USD	Annual
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$444.00M	USD	Annual
Proceeds from sale of subsidiaries and other assets	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$840.00M	USD	Annual
Proceeds from sale of subsidiaries and other assets	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$832.00M	USD	Annual
Proceeds from sale of subsidiaries and other assets	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	-	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-21.00M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-42.00M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-43.28B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.34B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.53B	USD	Annual
Net repayments of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-720.00M	USD	Annual
Net repayments of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	Annual
Net repayments of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-556.00M	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$9.96B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.74B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$44.34B	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$5.52B	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$8.34B	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$15.63B	USD	Annual
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$7.00M	USD	1 Quarter
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$25.00M	USD	Point-in-time
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$-446.00M	USD	Annual
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$25.00M	USD	Annual
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$7.00M	USD	Annual
Dividends paid	`PaymentsOfDividends`	$2.04B	USD	Annual
Dividends paid	`PaymentsOfDividends`	$2.62B	USD	Annual
Dividends paid	`PaymentsOfDividends`	$2.60B	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$264.00M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$242.00M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$210.00M	USD	Annual
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$88.00M	USD	Annual
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$112.00M	USD	Annual
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$97.00M	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-27.00M	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$1.00M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-8.15B	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-7.85B	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$36.82B	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-4.00M	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.40B	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.18B	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.66B	USD	Annual
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.90B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.90B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$7.19B	USD	Annual
Net income (loss)	`ProfitLoss`	$6.63B	USD	Annual
Net income (loss)	`ProfitLoss`	$-596.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.37B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.72B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.44B	USD	Annual
Goodwill impairments	`GoodwillImpairmentLoss`	-	USD	Annual
Goodwill impairments	`GoodwillImpairmentLoss`	-	USD	Annual
Goodwill impairments	`GoodwillImpairmentLoss`	$6.15B	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$453.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$280.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$400.00M	USD	Annual
(Gain) loss on sale of subsidiaries	`DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax`	$-269.00M	USD	Annual
(Gain) loss on sale of subsidiaries	`DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax`	$205.00M	USD	Annual
(Gain) loss on sale of subsidiaries	`DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax`	$86.00M	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.44B	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-674.00M	USD	Point-in-time
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	Point-in-time
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-766.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-570.00M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$87.00M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-654.00M	USD	Annual
Other noncash items	`OtherNoncashIncomeExpense`	$-72.00M	USD	Annual
Other noncash items	`OtherNoncashIncomeExpense`	$-253.00M	USD	Annual
Other noncash items	`OtherNoncashIncomeExpense`	$-264.00M	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.51B	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.16B	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.14B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.15B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.07B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$973.00M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-364.00M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$614.00M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$3.00M	USD	Annual
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.77B	USD	Annual
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$3.55B	USD	Annual
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.33B	USD	Annual
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$320.00M	USD	Annual
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$-311.00M	USD	Annual
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$-231.00M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.74B	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.48B	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$165.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$12.85B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.87B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$15.87B	USD	Annual

Stockholders Equity 45 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Decrease to accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.41B	USD	Point-in-time
Beginning of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
Decrease to accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.02B	USD	Point-in-time
Beginning of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Beginning of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Beginning of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Increase to retained earnings	`RetainedEarningsAccumulatedDeficit`	$49.64B	USD	Point-in-time
Increase to retained earnings	`RetainedEarningsAccumulatedDeficit`	$45.11B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$7.19B	USD	Annual
Net income (loss)	`ProfitLoss`	$6.63B	USD	Annual
Net income (loss)	`ProfitLoss`	$-596.00M	USD	Annual
Other comprehensive income (Note 13)	`OtherComprehensiveIncomeLossNetOfTax`	$917.00M	USD	Annual
Other comprehensive income (Note 13)	`OtherComprehensiveIncomeLossNetOfTax`	$395.00M	USD	Annual
Other comprehensive income (Note 13)	`OtherComprehensiveIncomeLossNetOfTax`	$274.00M	USD	Annual
Common shares issued to acquire Aetna	`StockIssuedDuringPeriodValueAcquisitions`	$22.48B	USD	Annual
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$421.00M	USD	Annual
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$532.00M	USD	Annual
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$541.00M	USD	Annual
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$7.00M	USD	Annual
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-7.00M	USD	Annual
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$57.00M	USD	Annual
Common stock dividends	`DividendsCommonStock`	$2.62B	USD	Annual
Common stock dividends	`DividendsCommonStock`	$2.04B	USD	Annual
Common stock dividends	`DividendsCommonStock`	$2.64B	USD	Annual
Acquisition of noncontrolling interests	`NoncontrollingInterestIncreaseFromBusinessCombination`	$329.00M	USD	Annual
Other decreases in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-7.00M	USD	Annual
Other decreases in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-9.00M	USD	Annual
Other decreases in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-13.00M	USD	Annual
End of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
End of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
End of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
End of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time

Comprehensive Income 27 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$7.19B	USD	Annual
Net income (loss)	`ProfitLoss`	$6.63B	USD	Annual
Net income (loss)	`ProfitLoss`	$-596.00M	USD	Annual
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$677.00M	USD	Annual
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$440.00M	USD	Annual
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$97.00M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$162.00M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$3.00M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-29.00M	USD	Annual
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$330.00M	USD	Annual
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-31.00M	USD	Annual
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-33.00M	USD	Annual
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$17.00M	USD	Annual
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$124.00M	USD	Annual
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-111.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$917.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$395.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$274.00M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.59B	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-322.00M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.55B	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.00M	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$13.00M	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.00M	USD	Annual
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$7.57B	USD	Annual
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$7.55B	USD	Annual
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$-320.00M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.